Correspondence: Dr CI Chen, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Suite 5-220, Toronto, Ontario, Canada M5G 2M9. E-mail: Christine.Chen@uhn.ca Numerous studies have reported the feasibility and safety of autologous SCT in patients with multiple myeloma and mild to moderate renal impairment, but there are limited data in dialysis-dependent patients.
http://ift.tt/1KlZLq5
http://ift.tt/1KlZLq5
No comments:
Post a Comment